Refine your search
Collections
Co-Authors
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Gupte, Satish
- Current Concepts in the Management of Head Injuries
Abstract Views :160 |
PDF Views:0
Authors
Satish Gupte
1,
M. A. Mufti
1
Affiliations
1 Government Medical College and S. M. G. S. Hospital Jammu, Kashmir, IN
1 Government Medical College and S. M. G. S. Hospital Jammu, Kashmir, IN
Source
The Indian Practitioner, Vol 28, No 1 (1975), Pagination: 31-36Abstract
No AbstractKeywords
No Keywords- Protein-calorie Malnutrition: Disturbances of Electrolyte and Mineral Metabolism
Abstract Views :204 |
PDF Views:0
Authors
Satish Gupte
1,
Suraj Gupte
1
Affiliations
1 Government Medical College & S. M. G. S. Hospital Jammu-180001, Kashmir, IN
1 Government Medical College & S. M. G. S. Hospital Jammu-180001, Kashmir, IN
Source
The Indian Practitioner, Vol 28, No 7 (1975), Pagination: 418-421Abstract
No AbstractKeywords
No Keywords- Smallpox
Abstract Views :205 |
PDF Views:0
Authors
Affiliations
1 Department of Pediatrics, Govt. Medical College & associated Hospitals, Jammu, Kashmir, IN
2 Department of Pathology, Govt. Medical College & associated Hospitals, Jammu, Kashmir, IN
3 Department of Obstetrics & Gynaecology, Lady Harding Medical College, New Delhi, IN
1 Department of Pediatrics, Govt. Medical College & associated Hospitals, Jammu, Kashmir, IN
2 Department of Pathology, Govt. Medical College & associated Hospitals, Jammu, Kashmir, IN
3 Department of Obstetrics & Gynaecology, Lady Harding Medical College, New Delhi, IN
Source
The Indian Practitioner, Vol 29, No 9 (1976), Pagination: 555-561Abstract
No AbstractKeywords
No Keyword- Nanobacteria - Present Status and Role in Human Diseases
Abstract Views :192 |
PDF Views:225
Authors
Affiliations
1 Department of Microbiology, Gian Sagar Medical College & Hospital, Punjab, 140601, IN
2 Department of Microbiology, GianSagar Medical College and Hospital, Banur, Punjab, IN
1 Department of Microbiology, Gian Sagar Medical College & Hospital, Punjab, 140601, IN
2 Department of Microbiology, GianSagar Medical College and Hospital, Banur, Punjab, IN
Source
SMU Medical Journal, Vol 2, No 2 (2015), Pagination: 241-248Abstract
The status of nanobacteria has been controversial, with some researchers suggesting they are a new class of living organism and others attributing to them a simpler, abiotic nature. They appear to be ubiquitous entities found in living and non-living substrates. Research has suggested that nanobacteria could be the cause of a wide variety of diseases, from kidney stones to atherosclerosis.References
- Kajander, E.O.; Ciftcioglu, N. (1998). Nanobacteria: An alternative mechanism for pathogenic intra- and extracellular calcification and stone formation. Proc. Natl. Acad. Sci. USA, 95(14), 8274-8279.
- Mckay D N, Mathew G, Kajander E (2006). "Nanobacteria: Fact Or Fiction? Characteristics, Detection, And Medical Importance Of Novel Self-Replicating, Calcifying Nanoparticles". J Investig Med 54 (7): 385-94
- Hopkin M.Nanobacteria theory takes a hit.http://www.nature.com/news/2008/080417/full/news.2008.762
- Ciftcioglu, N.; Bjorklund, M.; Kuorikoski, K.; Kajander, E.O. (1999).Nanobacteria: an infectious cause for kidney stone formation. Kidney Int., 56(5), 1893-1898
- McKay, David S.; et al. (1996). "Search for Past Life on Mars: Possible Relic Biogenic Activity in Martian Meteorite ALH84001". Science 273 (5277): 924-930
- Ciftcioglu, N., Kuronen, I., Åkerman, K., Hiltunen, E., Laukkanen, J. & Kajander. E. O. (1997) in Vaccines 97, eds. Brown, F., Burton, D., Doherty, P., Mekalanos, J. & Norrby, E. (Cold Spring Harbor Lab. Press, Cold Spring Harbor, NY), pp. 99-103.
- Uwins P J, Webb RI, and Taylor AP.(1998) Novel nano-organisms from Australian sandstones American Mineralogist, Volume 83, pages 1541-1550
- Martel J, Young JD; Young (April 2008). "Purported nanobacteria in human blood as calcium carbonate nanoparticles". Proc. Natl. Acad. Sci. U.S.A. 105(14): 5549-54.
- Kajander E O, Tahvanainen E, Kuronen I, Ciftcioglu N (1994) Zentralbl Bakteriol .Suppl126:147-149
- García-Cuerpo E, Kajander EO, Ciftcioglu N, et al.(2000) Nanobacteria: Un modelo de neo-litogenesis experimental. Arch. Esp. de Urol., 53:291-303.
- Miller VM, Rodgers G, Charlesworth JA, Kirkland B, Severson SR, Rasmussen TE, et al. (2004) Evidence of nanobacterial-like structures in calcified human arteries and cardiac valves. Am J Physiol Heart Circ Physiol 287:H1115e24.
- Ciftcioglu N, Kajander EO.(1998) Interaction of Nanobacteria with cultured mammalian cells. Pathophysiology 4:259-270.
- An overview on clinical implications of nanobacteria.Kumar CA, Bagga MB, Mohan V and Raghav N. (2011) J of Indian Academy of oral medicine and radiology,July 23(3)S354-359
- Moe OW. (2006) Kidney stones: pathophysiology and medical management. Lancet 367:333e44
- Aloisi G. (2008) An alternative origin for nanobacteria in kidney stones.Bioscience Hypotheses 1, 138e141
- Aloisi G, Gloter A, Kruger M, Wallmann K, Guyot F, Zuddas P (2006) Nucleation of calcium carbonate on bacterial nanoglobules. Geology 34(12):1017e20.
- Kajander EO. (2006) Nanobacteria-propagating calcifying nanoparticles.Lett Appl Microbiol. 42:549e52.
- Puskas LG, Tiszlavicz L, Razga Z, et al. (2005) Detection of nanobacteria-like particles in human atherosclerotic plaques. Acta Biol Hung 56: 233-245.
- Sedivy R, Battistutti WB. (2003) Nanobacteria promote crystallizationof psammoma bodies in ovarian cancer. AMPIS 111:951e4.
- Maniscalco BS, Taylor KA. (2004) Calcification in coronary artery disease can be reversed by EDTA-tetracycline long-term chemotherapy. Pathophysiology 11:95-101.
- Blaizot A, Vergnes JN, Nuwwareh S. (2009) Peri odontal diseases and cardiovascular events:Meta analysis of observational studies.Int Dent J 59:197-209
- Non-Fermenters - Emerging Health Care Pathogens
Abstract Views :238 |
PDF Views:168
Authors
Mandeep Kaur
1,
Satish Gupte
2,
Maninder Kaur
1,
Prerna Aggarwal
1,
Ashwini Manhas
1,
Manju Bala
1,
Tanveer Kaur
1
Affiliations
1 Department of Microbiology, Gian Sagar Medical College & Hospital, Rajpura, IN
2 Department of Microbiology, GianSagar Medical College and Hospital, Gian Sagar Medical College & Hospital, Rajpura, IN
1 Department of Microbiology, Gian Sagar Medical College & Hospital, Rajpura, IN
2 Department of Microbiology, GianSagar Medical College and Hospital, Gian Sagar Medical College & Hospital, Rajpura, IN
Source
SMU Medical Journal, Vol 2, No 2 (2015), Pagination: 266-277Abstract
Aerobic nonfermenting gram-negative bacilli (nonfermenters) are a heterogeneous group of organisms that are either incapable of utilizing carbohydrates as a source of energy or degrade them via oxidative rather than fermentative pathway. These organisms are common inhabitants of soil and water. Nonfermenters can cause a vast variety of infections and account for approximately 15%of all Gram negative bacilli cultured from clinical specimens. Their infection are endogenous or exogenous origin, depending on several factor such as use of immunosuppressant substance, abusive use of wide spectrum antimicrobial agents, prolong surgical procedure and inadequate instrumentation. Pseudomonas cause endocarditis, osteomyelitis, urinary tract infections, gastrointestinal infections, meningitis, and, commonly septicaemia. Acinetobacter has emerged as an important nosocomial organism causing infectious outbreaks in critically ill patients leading to high mortality and morbidity. Burkholderia cepacia shows fast growth on immune-depleted patients - like cystic fibrosis patients (CFPs). Sphingomonas paucimobilis can produce biofilms or attach to preexisting biofilms, where they become integrated and survive for days. Most infections caused by nonfermenters have been nosocomial, often related to contamination of hospital equipment or fluids and have occurred in immunocompromised hosts. Non-fermenting Gram-negative bacilli are innately resistant to many antibiotics and are known to produced extrended spectrum β-lactmases and metallo β-lactmases. This review article highlights the different clinical conditions caused by the nonfermenters.Keywords
Nonfermenters, Pseudomonas, Burkholderia cepacia, Acinetobacter, Sphingobacterium.References
- Koneman E.W., Allen S.D., Janda W.M., Schreckenberger P.C., Winn W.C.(2012) The nonfermentative Gram-negative bacilli. Color Atlas and Textbook of Diagnostic Microbiology. 6th Ed.
- Lippincott Williams and Wilkins,P. 309-375.
- Koneman E.W., Allen S.D., Rowell Jr V.R. et al. (1988) In Color atlas and textbook of diagnostic microbiology. 3th Ed. Lippincott, Philadelphia. P. 157-208, 493-534.
- Baron, E.J., Fine-old S.M. (1990) Nonfermentative gram-negative bacilli and coccobacilli. In: Bailey and Scott's Diagnostic microbiology, 8 th Ed. Mosby. 386-407.
- Siou Cing S.u.,Mario vaeechotte,Lenie Dijkshoorn,Y.u Fang Wei,Ya Lei Chen and Tsung Chain Chang. (2009) Identification of non-fermenting Gram-negative bacteria of clinical importance by an oligonucleotide array.Journal of Medical Microbiology ,58, 596-605.
- Cristiane Cunha Frota, Jose Luciano Bezerra Moreira. (1998) Frequency of nonfermentative gramnegative bacilli isolated from clinical materials of patients at universidade federal dodeara hospital complex Brazil Rev.Microbiol.vol.29 n.3 Sao Paulo.
- A Malini, E.K., deepa, B.N., Gokul,S.R. Prasad. (2009) Nonfermenting Gram-Negative Bacilli Infection in a tertiary care Hospital in kolar,Karnataka. Journal of laboratory PhysiciansVol-1.
- Willcox, M. D. (2007) Pseudomonas aeruginosa infection and inflammation during contact lens wear: a review. Optometry and Vision Science. Official Publication of the Journal of Infectious Diseases, 130 Suppl(0), S94-9.American Academy of Optometry. 84(4), 273-278.
- Liu, P. V.(1974) Extracellular toxins of Pseudomonas aeruginosa. The Journal of Infectious Diseases. 130 Suppl(0), 94-99.
- Feldman, M., Bryan, R., Rajan, S., Scheffler, L., Brunnert, S., Tang, H., & Prince, A. (1998) Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection. Infection and Immunity. 66(1), 43-53..
- Banerjee, D., & Stableforth, D. (2000) The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?. Drugs, 60(5), 1053-1064.
- Mena, K. D., & Gerba, C. P. (2009). Risk assessment of Pseudomonas aeruginosa in water. Reviews of Environmental Contamination and Toxicology. 201, 71-115.
- Pruitt, B. A., J.r., McManus, A. T., Kim, S. H., & Goodwin, C. W. (1998) Burn wound infections: current status. World Journal of Surgery. 22(2), 135-145.
- Nikaido H, Nikaido K, Harayama S. (1991) Identification and characterization of porins in Pseudomonas aeruginosa. J Biol Chem. 266,770–779.
- Jawad A, Snelling A.M., Heritage J, Hawkey P.M. (1998) Exceptional desiccation tolerance of Acinetobacter radioresistens.J Hosp Infect.39, 235–401.
- Fournier P.E. and Richet H. (2006) The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis. 42, 692-9.
- Talbot G.H., Bradley J, Edwards J.E., J.r., Gilbert D, Scheld M, Bartlett J.G. (2006) Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis .42, 657-668.
- Kilic A, Li H, Mellmann A, Basustaoglu A.C., Kul M, Senses Z, et al.(2008) Acinetobacter septicus sp. nov. association with a nosocomial outbreak of bacteremia in a neonatal intensive care unit. J Clin Microbiol. 46, 902-8.
- Jiang J.H., Chiu N.C., Huang F.Y., Kao H.A., Hsu C.H., Hung H.Y., et al.(2004) Neonatal sepsis in the neonatal intensive care unit: characteristics of early versus late onset. J Microbiol Immunol Infect .37, 301-6.
- Manikal V.M., Landman D, Saurina G, Oydna E, Lal H, Quale J. (2003) Endemic carbapenem resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis. 31,101–106.
- Hu, Q, Hu, Z, Li, J, Tian, B, Xu, H, Li, J . (2011) Detection of OXA-type carbapenemases and integrons among carbapenem-resistant Acinetobactor baumannii in a Teaching Hospital in China. J Basic Microbiol . 51, 467–472.
- Chiarini L, Bevivino A, Dalmastri C, Tabacchioni S, Visca P. (2006) Burkholderia cepacia complex species: Health hazards and biotechnological potential. Trends Microbiol.14, 277-86.
- Chu K.K., Davidson D.J., Halsey T.K., Chung J.W., Speert D.P.(2002) Differential persistence among genomovars of the Burkholderia cepacia complex in a murine model of pulmonary infection.Infect Immun .70, 2715-2720.
- Goldman L, Bennett J.C. CECIL: (2001) Textbook of Medicine (In Portuguese). 21th Ed. Guanabara Koogan: Rio de Janeiro.
- . Seo S.W., Chung I.Y., Kim E, Park J.M. (2008)A Case of Postoperative Sphingomonas paucimobilis endophthalmitis after cataract extraction. Korean Journal of Ophthalmology. 22(1), 63-65.
- Bulut C, Yetkin M.A,. Koruk S.T., Erdinç F.Ş., Karakoç E.A. (2008) Sphingomonas paucimobilis: A rare nosocomial bacteriemia agent. Mikrobiyol Bul. 42, 685-688.
- Koskinen R., Ali-Vehmas T., Kampfer P., Laurikkala M., Kostyal E., Atroshi F., and M. SalkinojaSalonen. (2000) Characterization of Sphingomonas isolates from Finnish and Swedish Drinking Water Distribution Systems. J. Appl. Microbiol.89, 687-696.
- Reina J, Borrell N, Figuerola J. (1992) Sphingobacterium multivorum isolated from a patient with cystic fibrosis. Eur J Clin Microbiol Infect Dis .11, 81-82.
- Fereny, Hansen W, Ploton C, Meugnier H, Madier S, Bornstein N, et al. (1987) Septicemia caused by Sphingobacterium multivorum. J Clin. Microbiol. 25, 1126-1128.
- Lambiase A, Rossano F, Pezzo M.D., Raia V, Sepe A, Gregorio F.D., et al. (2009) Sphingobacterium respiratory tract infection in patients with cystic fibrosis. BMC Res Notes. 2, 262.
- Marinella M.A. (2002) Cellulitis and sepsis due to Sphingobacterium. JAMA.288, 1985.
- Anaya D.A., Dellinger E.P. (2007) Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis. 44, 705-710.
- Calza L, Manfredi R, Chiodo F. (2003) Stenotrophomonas (Xanthomonas) maltophilia as an emerging opportunistic pathogen in association with HIV infection: a 10-year surveillance study.Infection .31, 155.
- de Oliveira-Garcia D, Dall'Agnol M, Rosales M, et al. (2003) Fimbriae and adherence of Stenotrophomonas maltophilia to epithelial cells and to abiotic surfaces. Cell Microbiol 5, 625–636.
- Vickers IE, Smikle MF. (2006) The immunomodulatory effect of antibiotics on the secretion of tumour necrosis factor alpha by peripheral blood mononuclear cells in response to Stenotrophomonas maltophilia stimulation. West Indian Med J. 55, 138-141.
- Windhorst S, Frank E, Georgieva D.N., Genov N, Buck F, Borowski P, Weber W. 2002) The major extracellular protease of the nosocomial pathogen Stenotrophomonas maltophilia. J Biological Chem.277, 11042-11049.
- Bizet J, Bizet C. (1997) Strains of Alcaligenes faecalis from clinical material. J Infect. 35,167–169.
- Bizet C, Tekaia F, Philippon A. (1993) In-vitro susceptibility of Alcaligenes faecalis compared with those of other Alcaligenes spp. to antimicrobial agents including seven β-lactams. J Antimicrob Chemother . 32, 907–910.
- Chag H.J., Christenson J.C., Pavia A.T., et al.(1996) Ochrobactrum anthropi meningitis in pediatric pericardial allograft transplant recipients. J Infect Dis. 173,656.
- Environmental Pathogens Related to Human Infections
Abstract Views :180 |
PDF Views:119
Authors
Affiliations
1 Department of Microbiology, Gian Sagar Medical College & Hospital, Rajpura, IN
1 Department of Microbiology, Gian Sagar Medical College & Hospital, Rajpura, IN
Source
SMU Medical Journal, Vol 2, No 2 (2015), Pagination: 286-294Abstract
Environmental pathogens are microorganisms that normally spend a substantial part of their lifecycle outside human hosts, but when introduced to humans cause diseases. They are borne in the water, soil, air, food, and other elements of our surroundings. Their adverse effects on human health cannot be controlled without first obtaining a thorough understanding of their environmental habitats and the epidemiology of the diseases they cause. To achieve this understanding, surveillance of the environment to determine the numbers and distribution of environmental pathogens is needed. The impacts of environmental pathogens can be felt by almost every person, So the public needs to be made better aware of their presence and risks. More study and research is needed on these environmental microbes for appropriate drug and vaccine development for the control of these infections. This review article highlights some of important environmental microbes associated with human infections.Keywords
Environmental Pathogens, Fomites, Biofilms, Aerosols.References
- Falkinham, J.O. (2009) III Surrounded by mycobacteria: nontuberculous mycobacteria in the human environment. J. Appl. Microbiol. 107, 356-367.
- Inderlied, C.B., Kemper C.A. and Bermudez, L.E. (1993) The Mycobacterium avium complex. Clin. Microbiol. Rev. 6, 266-310.
- Falkinham J.O.(2011) III Nontuberculous mycobacteria from household plumbing of patients with nontuberculous mycobacteria disease. Emerg. Infect. Dis. 17,419-424.
- Bukh, A.S. and Roslev, P. (2014) Mycobacterium avium complex in day care hot water systems, and persistence of live cells and DNA in hot water pipes. Curr. Microbiol. 68, 428-439.
- George, K.L., Parker, B.C., Ruft, H. and Falkinham, J.O. (1980) Epidemiology of infection by nontuberculous mycobacteria. Growth and survival in natural waters. Am. Rev. Respir. Dis. 122, 89-94.
- Norton, C.D., LeChevallier, M.W. and Falkinham, J.O. (2004) Survival of Mycobacterium avium in a model distribution system. Water Res. 38, 1457-1466.
- Embil, J., Warren, P., Yakrus, M., Stark, R., Corne, S., Forrest, D. and Hershfield, E. (1997) Pulmonary illness associated with exposure to Mycobacterium-avium complex in hot tub water. Chest. 111, 813-816.
- Sugita, Y. (2000) Familial cluster of cutaneous Mycobacterium avium infection resulting from use of a circulating, constantly heated bath water system. Br. J. Dermatol. 142, 789.
- Hugh-Jones, M. and Blackburn, J. (2009) The ecology of Bacillus anthracis. Molecular Aspects of Medicine. 30, 356-367.
- Blackburn, J.K., McNyset, K.M., Curtis, A., Hugh-Jones, M.E.((2007) Modeling the geographic distribution of Bacillus anthracis, the causative agent of anthrax disease, for the contiguous United States using predictive ecologic niche modeling. The American journal of tropical medicine and hygiene. 77, 1103- 1110.
- Joyner, T.A., Lukhnova, L., Pazilov, Y., Temiralyeva, G., Hugh-Jones, M.E. et al.(2010) Modeling the potential distribution of Bacillus anthracis under multiple climate change scenarios for Kazakhstan. PloS one 5, e9596.
- Mullins, J., Lukhnova L., Aikimbayev A., Pazilov Y., Van Ert M. et al.(2011) Ecological Niche Modelling of the Bacillus anthracis A1. a sub-lineage in Kazakhstan. BMC ecology. 11, 32.
- Christie, A.B. (1987) Anthrax. Infectious Diseases: Epidemiology and Clinical Practice. Edinburgh: Churchill Livingstone. 4, 100-164.
- Nguyen, V.T., Fegan, N., Turner, M.S., Dykes, G.A. (2012) Role of attachment to surfaces on the prevalence and survival of Campylobacter through food systems. J. Food Prot. 75,195-206, .
- Joshua, G.W.P., Guthrie-Irons, C., Karlyshev, A.V., Wren, B.W.(2006) Biofilm formation in Campylobacter jejuni. Microbiology. 152:387-396.
- Stanley, K., and Jones, K.(2003) Cattle and sheep farms as reservoirs of Campylobacter. J.Appl. Microbiol. 94, 104S-113S.
- Taylor, E. V., Herman, K. M., Ailes, E. C. Fitzgerald, C., Yoder, J. S., Mahon, B. E. and Tauxe, R. V. (2013) Common source outbreaks of Campylobacter infection in the USA, 1997-2008.Epidemiol. Infect.141, 987-996.
- Park, S.F. (2002) The physiology of Campylobacter species and its relevance to their role as foodborne pathogens. Int. J. Food Microbiol. 74,177-188.
- Martinez-Rodriguez, A., Kelly, A.F., Park, S.F., Mackey B.M.(2004) Emergence of variants with altered survival properties in stationary phase cultures of Campylobacter jejuni. Int. J. Food Microbiol. 90, 321-329.
- Baylis, C.L., MacPhee, S., Martin, K.W., Humphrey, T.J. and Betts, R.P. (2000) Comparison of three enrichment media for the isolation of Campylobacter spp. from foods. J. Appl. Microbiol. 89, 884-891.
- Buswell, C.M., Herlihy, Y.M., Lawrence L.M., McGuiggan, J.T.M., Marsh, P.D., Keevil, C.W., Leach, S.A. (1988) Extended survival and persistence of Campylobacter spp. in water and aquatic biofilms and their detection by immunofluorescent- antibody and -rRNA staining. Appl. Environ.Microbiol. 64, 733-742.
- Hadler, J.L. (2014) Legionnaires’ disease caused by Legionella pneumophila Serogroups 5 and 10. China Emerging Infectious Diseases. www.cdc.gov/eid . Vol. 20, 7,1242-1243.
- Gerard, A., Cangelosi, Nancy, E., Freitag, and Buckley, M.R. From outside to inside: Environmental microbes as human pathogens. 2005.Colloquium Report. American Academy of Microbiology, held onFebruary 6-8, 2004, in Portland, Oregon.
- Kim, C., Jeon,S., Jung,J. et al.(2015) Isolation of Legionella pneumophila from cooling towers, public baths, hospitals, and fountains in seoul, korea, from 2010 to 2012. Journal of Environmental Health. 77(6), 58-62.
- ILSI Research Foundation, & Risk Science Institute Expert Panel on Listeria monocytogenes in Foods. Achieving continuous improvement in reductions in foodborne listeriosis-a risk-based approach. Journal of Food Protection. (2005), 68(9), 1932-1994.
- El-Shenawy, M.A., and El-Shenawy, M.A. (2006) Listeria spp. in the coastal environment of the Aqaba Gulf, Suez Gulf, and the Red Sea. Epidemiology and Infection. 134(4), 751-757.
- Hellstrom, S., Kiviniemi, K., Autio, T., and Korkeala, H. (2008) Listeria monocytogenes is common in wild birds in Helsinki region and genotypes are frequently similar with those found along the food chain. Journal of Applied Microbiology.104(3), 883-888.
- Thimothe, J., Nightingale, K.K., Gall, K., Scott, V.N., and Wiedmann, M. (2004) Tracking of Listeria monocytogenes in smoked fish processing plants. Journal of Food Protection. 67(2), 328-341.
- Vazquez-Salinas, C., Rodas-Suarez, O., and Quinones-Ramirez, E.I. (2001) Occurrence of Listeria monocytogenes species in raw milk in farms on the outskirts of Mexico City. Food Microbiology. 18(2), 177-181.
- Tompkin, R.B.(2002) Control of Listeria monocytogenes in the food-processing environment.Journal of Food Protection. 65(4),709-725.
- Doyle, M.E., Mozzotta, A.S., Wang, T., (2001) Wiseman, D.W. and Scott, V.N. Heat resistance of Listeria monocytogenes. Journal of Food Protection. 64(3), 410-429.
- Waak, E., Tham, W., and Danielsson-Tham, M.L. (2002) Prevalence and fingerprinting of Listeria monocytogenes strains isolated from raw whole milk in farm bulk tanks and dairy plant receiving tanks. Applied and Environmental Microbiology. 68(7), 3366-3370.
- Current Concepts of Commonly Used Vaccines
Abstract Views :196 |
PDF Views:110
Authors
Affiliations
1 Department of Microbiology, Gian Sagar Medical College & Hospital, Rajpura, IN
2 Department of Microbiology, GianSagar Medical College and Hospital, Banur, Punjab, IN
1 Department of Microbiology, Gian Sagar Medical College & Hospital, Rajpura, IN
2 Department of Microbiology, GianSagar Medical College and Hospital, Banur, Punjab, IN
Source
SMU Medical Journal, Vol 2, No 2 (2015), Pagination: 306-316Abstract
Today's world need vaccines for the prevention of infectious diseases, cancer therapy, and many more. Vaccines reduce the mortality rates in the world from infectious diseases such as measles, polio and diphtheria. The concept of vaccination is very old. Conventional vaccines are composed of Live or Attenuated microorganisms. But they may not be sufficient in current scenario, so further research is going on for development of vaccine which should be cost-effective and having specific immune responses. The current concept of vaccines is a challenge which could produce both humoral and cell-mediated immunity. In this review we are discussing about the types, concept, economics, and newer trends for vaccines production.Keywords
Vaccines, Types, Concept, Trends.References
- Judy owen , jenni punt & Sharon stranford, M.(2013) kuby immunology :vaccine, 7th Ed.US: W.H.freeman.ISBN-9781464137846
- Pasteur, Louis (1881). "Address on the Germ Theory". Lancet 118 (3024): 271-2.doi:10.1016/s0140-6736(02)35739-8.
- "Vaccine Types". Niaid.nih.gov. 2012-04-03. Retrieved 2013-04-26.
- Kim W, Liau LM (2010). "Dendritic cell vaccines for brain tumors". Neurosurg Clin N Am21 (1): 139–57. doi:10.1016/j.nec.2009.09.005. PMC 2810429. PMID 19944973.
- Meri, S; Jördens, M; Jarva, H (2008). "Microbial complement inhibitors as vaccines". Vaccine. 26 Suppl 8: I1137. doi:10.1016/j.vaccine.2008.11.058.PMID 19388175.
- Jit, Mark; Newall, Anthony T.; Beutels, Philippe (2013). "Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies". Human vaccines & immunotherapeutics 9 (4): 834–840. doi:10.4161/hv.23637.
- "Thimerosal in vaccines". Center for Biologics Evaluation and Research, U.S. Food and Drug Administration. 2007-09-06. Retrieved 2007-10-01.
- Plotkin SA (2005). "Vaccines: past, present and future". Nat Med 11 (4 Suppl): S5– 11. doi:10.1038/nm1209. PMID 15812490.
- "Safer vaccine created without virus". March 28, 2013. Retrieved March 28, 2013.
- Sala, F.; Manuela Rigano, M.; Barbante, A.; Basso, B.; Walmsley, AM; Castiglione, S (2003). "Vaccine antigen production in transgenic plants: strategies, gene constructs and perspectives". Vaccine 21 (7–8): 803–8. doi:10.1016/s0264-410x(02)006035. PMID 23888738.
- Kumar, G. B. Sunil; T. R. Ganapathi, C. J. Revathi, L. Srinivas and V. A. Bapat (2005). "Expression of hepatitis B surface antigen in transgenic banana plants". Planta222 (3): 484–493. doi:10.1007/s00425-005-1556-y. PMID 15918027
- Influenza A (H1N1) 2009 Monovalent Vaccine http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm181950.htm
- AIDSinfo Vaccine Web page at http://aidsinfo.nih.gov/ Vaccines/
- Zhang VM, Chavchich M, Waters NC (2012). "Targeting protein kinases in the malaria parasite: update of an antimalarial drug target". Curr Top Med Chem 12 (5): 456– 72. doi:10.2174/156802612799362922. PMID 22242850.
- Prabowo, S. et al. (2013) "Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines." Med Microbiol Immunol 202: 95-1041. Print.
- White, A. et al. (2013) "Evaluation of the Safety and Immunogenicity of a Candidate Tuberculosis Vaccine, MVA85A, Delivered by Aerosol to the Lungs of Macaques." Clinical and Vaccine Immunology 20 : 663-672.
- Clinical Significance of Viral Diagnosti
Abstract Views :168 |
PDF Views:145
Authors
Nitya Batra
1,
Satish Gupte
1,
Prerna Aggarwal
1,
Maninder Kaur
1,
Ashwini Manhas
1,
Manju Bala
1,
Ravi Kumar
1
Affiliations
1 Department of Microbiology, GianSagar Medical College and Hospital, Banur, Punjab, IN
1 Department of Microbiology, GianSagar Medical College and Hospital, Banur, Punjab, IN
Source
SMU Medical Journal, Vol 2, No 1 (2015), Pagination: 291-298Abstract
Diagnostics in virology has become a very important tool in both diagnosis and prognosis of a disease. Rapid and accurate diagnosis of an infection should enhance patient outcome by enabling early initiation of appropriate therapy and thus implementation of relevant infection-control measures. Virological diagnostic methods may be implemented as adjuncts to the epidemiologic investigation of infectious disease outbreaks.Thus, paving a way for the development of newer antiviral drugs. Molecular diagnostics has helped in overcoming the various challenges and has helped the clinicians in determining the appropriate therapy to be initiated.- Ebola Virus Vaccines
Abstract Views :239 |
PDF Views:124
Authors
Nitya Batra
1,
Satish Gupte
1,
Prerna Aggarwal
1,
Maninder Kaur
1,
Ashwini Manhas
1,
Manju Bala
1,
Ravi Kumar
1
Affiliations
1 Department of Microbiology, GianSagar Medical College and Hospital, Banur, Punjab, IN
1 Department of Microbiology, GianSagar Medical College and Hospital, Banur, Punjab, IN
Source
SMU Medical Journal, Vol 2, No 1 (2015), Pagination: 330-334Abstract
Ebola hemorrhagic fever, an extremely fatal viral disease is caused by Ebola virus. The African subcontinent is experiencing the most fatal epidemic caused by this virus. Recently, a few cases have been detected outside Africa. Thus, this is of concern and has alerted World Health Organization (WHO). Currently there is no cure for Ebola, nor is there a vaccine approved yet for human use. A few vaccines are under clinical trials. Thus, there needs to be an integrated approach in prevention of this fatal disease by an effective vaccine formation.- Current Concept of New-Delhi Metallo Beta Lactamases (NDM)
Abstract Views :232 |
PDF Views:174
Authors
Ravikant
1,
Satish Gupte
2,
Prerna Aggarwal
1,
Maninder Kaur
3,
Ashwini Manhas
1,
Manju Arora
1,
Mrinangka Dev
1
Affiliations
1 Department of Microbiology, Gian Sagar Medical College & Hospital, Banur, Punjab, IN
2 Gian Sagar Medical College & Hospital, IN
3 Department of Microbiology, Gian Sagar Medical College & Hospital, Banur, Punjab
1 Department of Microbiology, Gian Sagar Medical College & Hospital, Banur, Punjab, IN
2 Gian Sagar Medical College & Hospital, IN
3 Department of Microbiology, Gian Sagar Medical College & Hospital, Banur, Punjab
Source
SMU Medical Journal, Vol 1, No 2 (2014), Pagination: 88-101Abstract
The emergence of superbugs intermittently has always been a global threat for control and treatment of infectious disease caused by them over many decades which influence human population with their mutated genetic make-up and mechanics of resistance. However, bacteria have been developing resistance to antibiotics since they were introduced in 1930s. From the year 1961 till date, among some of the more common superbugs are methicillin-resistant Staphylococcus aureus (MRSA) and drug resistant tuberculosis (MDR-TB and XDR-TB). The latest superbug encodes the gene for New Delhi metallo-beta-lactamase (NDM-1) is an enzyme that can hydrolyze and inactivate carbapenems, which are used as a last resort for the treatment of multi-resistant bacterial infection. Escherichia coli and Klebsiella pneumoniae commonly expresses the gene for NDM-1 moreover NDM-2 in Acinetobacter baumannii, NDM-4, NDM-5, NDM- 6, NDM-7 and NDM-8 from E.coli and other Enterobacteriaceae also have been reported. Research is on to develop new classes of antibiotic to handle these threats and it is worrying as there are very limited therapeutics available in the development pipeline that works effectively in the current situation.- Microbial Biofilms
Abstract Views :412 |
PDF Views:161
Authors
Mrinangka Deb
1,
Satish Gupte
2,
Prerna Aggarwal
1,
Maninder Kaur
1,
Ashwini Manhas
1,
Manju Bala
1,
Ravi Kant
1
Affiliations
1 Department of Microbiology, Gian Sagar Medical College and Hospital (GSMCH), Punjab-140601, IN
2 Gian Sagar Medical College & Hospital, IN
1 Department of Microbiology, Gian Sagar Medical College and Hospital (GSMCH), Punjab-140601, IN
2 Gian Sagar Medical College & Hospital, IN
Source
SMU Medical Journal, Vol 1, No 2 (2014), Pagination: 116-127Abstract
Biofilm formation constitutes an alternative lifestyle in which microorganisms adopt a multicellular behavior that facilitates and/or prolongs survival in diverse environmental niches. Biofilms form on biotic and abiotic surfaces both in the environment and in the healthcare setting. In hospital wards, the formation of biofilms on vents and medical equipment enables pathogens to persist as reservoirs that can readily spread to patients. Inside the host, biofilms allow pathogens to subvert innate immune defenses and are thus associated with long-term persistence. This review describes the process of biofilm formation its composition and virulence and the role it plays in the pathogenisis of various infections mostly chronic. The review also makes an attempt to describe antimicrobial biofilm control.- Therapeutic Replacements to Antibiotics
Abstract Views :218 |
PDF Views:115
Authors
Affiliations
1 Department of Microbiology, Gian Sagar Medical College and Hospital, Rajpura, IN
1 Department of Microbiology, Gian Sagar Medical College and Hospital, Rajpura, IN
Source
SMU Medical Journal, Vol 3, No 1 (2016), Pagination: 211-230Abstract
For more than half a century, the human society has been relying primarily on antibiotics to treat infectious diseases caused by pathogenic bacteria. After the development of antibiotics, a general belief arose that the problem of bacterial infections would be solved. But the more use of antibiotics for the treatment of bacterial infection resulting in Multidrug-resistant bacterial infections. The emergence of infectious disease caused by drug-resistant bacteria requires alternatives to conventional antibiotics. Immunity play important role to treat infectious diseases. Certain type of immunomodulators are used to boost the immunity against infectious diseases. Immunomodulators are biological or synthetic substances that can modulate any aspect of the immune system including both adaptive and innate arms of the immune system. Vaccines play an important role in providing and improving immunity to a particular disease. Monoclonal antibodies are currently being developed against certain infectious agents, including cytomegalovirus and human immunodeficiency virus. Prebiotics and probiotics are used to promote the growth and multiplication of specific beneficial gut microflora. Micronutrients such as selenium, zinc, and vitamin A and macronutrient such as Protein, Fat, Carbohydrates known to modulate immunity . Bacteriophages, Bacterial cell wall hydrolases and Antimicrobial peptides are also used as alternative to antibiotics in certain bacterial infections. Bacteriophages are 'bacterium eaters' that kill bacterium by causing its lysis (bacteriolysis). This review article highlights various types of alternatives to antibiotics which are used for the treatment of bacterial infections.Keywords
Antibiotics, Immunity, Vaccine, Bacteriophages, Antimicrobioal Peptides.- Current Concepts of Medical Microbiology Laboratory
Abstract Views :258 |
PDF Views:124
Authors
Affiliations
1 Department of Microbiology, Gian Sagar Medical College and Hospital, Rajpura, IN
1 Department of Microbiology, Gian Sagar Medical College and Hospital, Rajpura, IN